Findings
========

Japanese encephalitis virus (JEV) is the most important causes of epidemic encephalitis in Southeast Asia and Western Pacific regions, with an estimated 35,000 to 50,000 cases each year, and approximately 1-3 of every 1000 JEV infections resulting in severe disease \[[@B1]\]. JEV is a small, enveloped virus with a single-stranded, positive-sense RNA genome of approximately 11,000 nt. Its ORF is translated into a large polyprotein that includes three structural proteins (C, prM and E) and seven non-structural proteins (NS1, NS2A, NS2B, NS3, NS4A, NS4B and NS5) \[[@B2]\]. Since the first JEV isolate was reported in 1949, JE epidemics have occurred in China, and Chongqing is listed as the region of highest incidence. However, no clinical JEV strain has been isolated from human cerebrospinal fluid (CSF), serum or brain tissue of fatal cases in Chongqing; thus, the molecular characteristics and genetic diversity of clinical JEV strains remain unknown.

In this study, acute serum and CSF specimens were collected from patients who were clinically diagnosed with Japanese encephalitis (JE) during July to October in 2011 and hospitalized in the Children's Hospital of Chongqing Medical University. Serum specimens were diluted in minimal essential medium at a ratio of 1 to 5, pretreated with 100 U ml^-1^ penicillin and streptomycin and placed for at least four hours at 4°C. CSF specimens were incubated directly. A monolayer of BHK-21 cells was grown to 90% confluence and incubated with either CSF or diluted serum at 37°C. Once cytopathic effects (CPE) were observed in a culture, viruses were harvested from the culture medium by centrifugation at 10,000 rpm for 10 min. Viral RNA was extracted from the supernatant (140 μL) of infected BHK-21 cells cultures using the QIAamp® Viral RNA kit (QIAGEN; USA). RNA was reverse-transcribed using a random primer and amplified with a Go Tag® Hot Start Polymerase kit (Promega; USA). The full-length genome was amplified by polymerase chain reaction (PCR) with TaKaRa LA Taq polymerase (TaKaRa; China) using seven pairs of primers (Table [1](#T1){ref-type="table"}). The PCR reaction conditions were as follows: 3 min of cDNA denaturation at 94°C, followed by 30 cycles of 94°C denaturation for 30 sec, 55°C primer annealing for 30 sec, and 72°C primer extension for 1 min. Amplified products were examined by agarose gel electrophoresis (1%), purified with a Takara MiniBEST Agarose Gel DNA Extraction Kit Ver 3.0 (TaKaRa; China) and sent to TaKaRa for commercial sequencing. The full-length genome of the strains was compiled using the SeqMan program in the Lasergene software package (DNASTAR). The percentage similarities between aligned nucleotide or amino acid sequences were calculated using MEGA 5 software. Phylogenetic analysis was performed by the neighbor-joining (NJ) method using MEGA5 software. For the previously published JEV strain sequences, the host background, year of isolation, geographic origin and GenBank accession number are listed in Table [2](#T2){ref-type="table"}. Multiple sequence alignments and the NJ tree were generated by ClustalX (1.8). The genomic sequence of 21 strains and the E gene sequence of 30 strains were employed in the generation of the phylogenetic trees. The bootstrap probabilities of each node were calculated using 100 replicates.

###### 

Primers for nucleic acid amplification assays

   **Name**   **5**^**′**^ -**3**^**′**^   **Length**
  ---------- ---------------------------- ------------
   PrimerF1      AGTATCGTTGAGAAGAATCG          20
   PrimerF2     TATGCTTTCCTGGCGGCGGTAC         22
   PrimerF3     GAAGGGGAGACAAGCAGATCAA         22
   PrimerF4     CTGCAAGAGAGGAAAAAGACCA         22
   PrimerF5     GGAGGGGCAGAGTAGGCAGAAA         22
   PrimerF6     CCGTTGGCTCGTGGAGAAAGGA         22
   PrimerF7     TCAGCGGAGATGACTGTGTCGT         22
   PrimerR1     CCTTCATTTCCTCCTCTTTTGT         22
   PrimerR2     TGAACGGCTTTTCCTATGGAGT         22
   PrimerR3     CAAACATCAATCCAACTGCCGA         22
   PrimerR4     AGTCCATTGGGCATGTGTATGT         22
   PrimerR5     TCTGCATGAGCATCGGTTCTTC         22
   PrimerR6     AAATGGTTAGAGCAGAAGGGAA         22
   PrimerR7     TCTTCCTCACCACCAGCTACAT         22

###### 

Bankground of Japanese encephalitis virus strains used in this study

   **Strain**    **Source**     **Genotype**   **Geographical location**   **Year**   **GenBank accession no./reference**  
  ------------ --------------- -------------- --------------------------- ---------- ------------------------------------- ------------
   Beijing-1        Human           III                  China               1948                   L48961                    L48961
     CH1392       Mosquito          III                 Taiwan               1990                  AF254452                  U44960.1
       FU           Human            II                Australia             1995                  AF217620                  L43565.1
      GP78          Human           III                  India               1978                  AF075723                  AF075723
   SA14-14-2    Vaccin strain       III                  China               1954                 AF315119.1                AF315119.1
    JaGAr01       Mosquito          III                  Japan               1959                  AF069076                  AF069076
      WTP         Mosquito           II                Malaysia              1970                  HQ223286                   U70421
     K94P05       Mosquito           I                   Korea               1994                   AF04555                   U34929
    JKT5441       Mosquito           II                Indonesia             1981                  AF045551                   U34929
    JKT6468       Mosquito           IV                Indonesia             1981                  AY184212                   U70407
    Ishikawa      Mosquito           I                   Japan               1998                  AB051292                  AB051292
      Ling          Human           III                 Taiwan               1965                   L78128                    L78128
      RP-9        Mosquito          III                 Taiwan               1985                  AF014161                  AF014161
       47           Human           III                  China              1950s                  AY243827                  AY243827
      SA14        Mosquito          III                  China               1960                   U14163                   AY243850
     K87P39       Mosquito          III                  Korea               1987                  AY585243                  AY585243
     P20778         Human           III                  India               1958                  AF080251                   Z34096
    CH21955A      Mosquito          III                 Taiwan               1994                  AF221500                  AF221500
      ML11         Vaccine          III                  Japan               1981                  AY508812                   U70412
   jaOArS982      Mosquito          III                  Japan               1982                   M18370                    M18370
    Nakayama        Human           III                  Japan               1935                  EF571853                  AF112297
    JKT7003       Mosquito           IV                Indonesia             1981                                             U70408
    Sagiyama      Mosquito          III                  Japan               1957                                             U70419
    Kamiyama        Human           III                  Japan               1966                                            AB379813
     K82P01       Mosquito          III                  Japan               1982                                             U34926
     826309         Human           III                  India               1982                                             Z34094
   ThCMAr6793     Mosquito           I                 Thaliand              1993                                             D45363
    JKT1724       Mosquito          III                Indonesia             1979                                             U70404
     SH-53        Mosquito           I                   China               2001                                            AY555757
    PhAn1242         Pig            III               Philippines            1984                                             U70417

In total, only one cell culture incubated with a patient CSF sample, named CQ11-66, tested positive by PCR, and none of the cell cultures incubated with patient serum samples tested positive. The genome sequence of CQ11-66 was 10,863 nucleotides in length, with an open reading frame (ORF) (GenBank: KC183732) of 10,296 nt coding for a polyprotein. When comparing its ORF with that of 21 other JEV strains isolated from different geographic regions or periods, high levels of similarity were observed, with nucleotide divergence ranging from 1.68% to 18.46%, and amino acid divergence ranging from 0.32% to 4.89%. A comparison of the CQ11-66 polyprotein ORF with that of SA14-14-2, the attenuated JEV vaccine strain currently widely used in China, discovered a total of 201 nucleotide differences (1.96%) and 42 amino acid differences (1.23%).

The nucleotide and amino acid sequences of the CQ11-66 strain E region were compared with those of other isolates available in GenBank. This analysis revealed that nucleotide divergence ranged from 1.62% to 18.74%, while deduced amino acid divergence ranged from 1.01% to 5.13%. Among these amino acid mutations, the E408 (Arg to Lys) variation was unique to CQ11-661. A comparison of the CQ11-66 strain E gene with that of SA14-14-2 also indicated 36 nucleotide changes, resulting in 15 amino acid changes: E76 (Thr to Met), E107 (Phe to Leu), E138 (Lys to Glu), E176 (Val to Thr), E177 (Ala to Thr), E209 (Lys to Arg), E227 (Ser to Pro), E244 (Gly to Glu), E264 (His to Gln), E279 (Met to Lys), E306 (Glu to Gly), E315 (Val to Ala), E408 (Arg to Lys), E416 (Asp to Gly) and E439 (Asp to Gly). On the basis of the ORF gene sequences of 22 JEV isolates and the E gene sequences of 31 JEV isolates, phylogenetic trees were constructed (shown in Figures [1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}). Both phylogenetic trees provided similar topology, and the analysis indicated that the CQ11-66 strain belonged to genotype III.

![**Phylogenetic tree constructed by the neighbor-joining method, based on the polyprotein ORFs of selected Japanese encephalitis virus strains.** The CQ11-66 China 2011 human obtained in this study is shown in bold face.](1743-422X-10-101-1){#F1}

![**Phylogenetic tree constructed by the neighbor-joining method, based on the envelope (E) protein gene of selected Japanese encephalitis virus strains.** The CQ11-66 China 2011 human obtained in this study is shown in bold face.](1743-422X-10-101-2){#F2}

On the basis of 240 nucleotide of the C/prM gene, JEV strains were divided into five genotypes two decades ago \[[@B3],[@B4]\]. However, the functional significance of the prM genetic variations remains to be established, and genetic relationships based on short sequences (\<300 nt) should be required to take into account the biological significance and may be considered with caution \[[@B5],[@B6]\]. Subsequently, the full-length E gene of JEV and its deduced protein sequence have been used as reliable phylogenetic markers, given that the E protein plays an important role in the JEV life cycle \[[@B7]\]. In China, many JEV strains belonging to genotype I and genotype III have been reported, and it was suggested by surveillance data that genotype I strains have been gradually replacing genotype III as the dominant strains in Asia. Due to limited sequence information regarding JEV isolates in Chongqing, the dominant genotype in one of the high-incidence regions in China remains unclear. In this study, phylogenetic analyses employing the ORF and E gene sequence of the CQ11-66 strain indicated it belonged to genotype III.

The crystallographic structure of the E protein of the flavivirus tick-borne encephalitis virus revealed that the E protein consists of three domains. The difference in the E gene of JEV strains, particularly in domain III \[[@B8]\], may contribute to the diversity of neutralizing and antigenic properties \[[@B9]\]. Previous research has also indicated that mutations in domain III modulated virus binding and entry into host cells \[[@B10],[@B11]\]. In this study, comparison of the E gene of CQ11-66 strain with the vaccine strain SA14-14-2 revealed 15 amino acid substitutions. Among these variations, the Glu to Lys alteration at position 138 is consistent with previous observations that the E138 mutation is associated with attenuation of the JEV strain and inhibits viral spread from cell to cell \[[@B12]\]. Other groups have also demonstrated that mutations of residues E49, E138, E306 and E389 of the E protein reduce the efficiency of viral binding to heparan sulphate residues on target cells \[[@B13]\]. In our results, a substitution (Met to Lys) was observed at the position E279, which may increase virulence in mice \[[@B14]\].

Genetic variation among JEV strains isolated from widely different time periods and geographical regions has been reported in many studies \[[@B13]\]. A previous study examining 46 JEV strains found that those from a much wider geographic region and at certain time period were similar, but that genetic variation was present among strains from diverse regions or from different time periods in the same region. These observations suggested JEV is continuously evolving \[[@B15]\]. Meanwhile, Yun et al. \[[@B16]\] reported that the E gene sequences of the 10 Korean JEV strains, despite differences in their geographic distributions and the maximum five-year time span, showed remarkable genetic stability. Such stability in the JEV genome was also observed in strains from China and Japan \[[@B17],[@B18]\]. In this study, phylogenetic analyses of the CQ11-66 ORF and the ORF of 21 other JEV strains isolated from several countries revealed the lowest nucleotide divergence and the lowest amino acid divergence with the JaGA01 strain. Meanwhile, phylogenetic analyses of its E gene and the E gene of 30 other JEV strains revealed the lowest nucleotide divergence and the lowest amino acid divergence with the JaGA01 strain.

In conclusion, we have isolated a JEV strain from a JE patient in Chongqing, China. Molecular analysis of the nucleotide and amino acid sequences indicated that CQ11-66 belonged to genotype III, and comparison of the ORF sequence and the E gene sequence with other strains from different regions at different periods revealed high homology.
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